Annual Meeting

Out with the old, in with the nucleus

Learn about the Discover BMB 2024 symposium on signaling mechanisms in the nucleus
Glen Liszczak Aaron Johnson
By Glen Liszczak and Aaron Johnson
Sept. 21, 2023

Are you tired of binging reruns on Netflix?  Maybe you need a break from reality TV but you’re not sure where to turn for high-quality entertainment?  Look no further — the nucleus has it all.  There’s mystery, murder, machines of extraordinary complexity and visually stunning landscapes. 

Stories in nuclear signaling are unraveling at an unprecedented pace thanks to technological and conceptual advances in chemistry, biochemistry and cell biology. Our speakers will address long-standing questions about organism development, cellular identity and the genetic basis for disease. 

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

You will hear about how cutting-edge interdisciplinary approaches are being used to uncover new regulatory mechanisms underlying transcription, genome structure, and other phenomena in the nucleus. We will also discuss how rapid progress in the field is inspiring new therapeutic approaches for diseases related to dysfunctional nuclear processes.

You don’t want to miss this — even the cytosol junkies will be on the edge of their seats.

Keywords:  Enzyme mechanism, genetics and disease, chemical probes, transcription regulation, chromatin modifications, genome structure.

Who should attend: You. Our speakers span a wide breadth of biological phenomena, scientific disciplines and technologies. We have something for everyone. Current projections: standing room only.

Your session’s theme song“Journey to the Island” by John Williams

This song is about the most important genetics experiment ever performed.

This session is powered by “hot, nasty, bad-*ss speed.” — Eleanor Roosevelt, Talladega Nights

Signaling mechanisms in the nucleus

Chemical strategies to study nuclear processes

Chair: Aaron Johnson

Anna MappUniversity of Michigan

Glen LiszczakUniversity of Texas Southwestern Medical Center

Oliver BellUniversity of Southern California Kerk School of Medicine

Minkui LuoMemorial Sloan Kettering Cancer Center

Chromatin organization, replication and repair

Chair: Katharine Diehl

Aaron StreetsUniversity of California, Berkeley

Aaron JohnsonUniversity of Colorado Anschutz Medical Campus

Carl WuJohns Hopkins University

Serena Sanulli, Stanford University

Chromatin modifications in the nucleus

Chair: Glen Liszczak

Alex RuthenbergUniversity of Chicago

Katharine DiehlUniversity of Utah

Tim StasevichColorado State University

Phil ColeHarvard University

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Glen Liszczak
Glen Liszczak

Glen Liszczak is an assistant professor in the biochemistry department at the University of Texas Southwestern Medical Center.

Aaron Johnson
Aaron Johnson

Aaron Johnson is an associate professor in the biochemistry and molecular genetics department at the University of Colorado School of Medicine.

Related articles

Processing and translating RNA in health and disease
Katrin Karbstein & Jeremy Wilusz
Enzymes: Still cool after all these years
Shelley Copley & Hung-wen (Ben) Liu
Enzymes show off new moves
Tadhg Begley & Catherine Drennan

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

‘Inert’ ingredients in pesticides may be more toxic to bees than scientists thought
News

‘Inert’ ingredients in pesticides may be more toxic to bees than scientists thought

Dec. 9, 2023

Pesticide users sometimes know very little about how inerts function. That’s partly because they are regulated very differently than active ingredients.

FDA approves CRISPR–Cas9 therapy for sickle cell disease
News

FDA approves CRISPR–Cas9 therapy for sickle cell disease

Dec. 8, 2023

The gene editing treatment from Vertex Pharmaceuticals and CRISPR Therapeutics is the first of its kind

From the journals: MCP
Journal News

From the journals: MCP

Dec. 8, 2023

Metals contaminate protein samples. Lipid droplets go haywire in Huntington’s. Nerve cells respond to stimulation. Read about these recent papers.

The perfect storm
Feature

The perfect storm

Dec. 6, 2023

The world has 2023 Nobel laureates Katalin Karikó, Drew Weissman and others to thank for laying a foundation for the COVID-19 vaccine decades before the pandemic.

Throw your hat in the ring!
Annual Meeting

Throw your hat in the ring!

Dec. 6, 2023

Apply to speak at Discover BMB in Chicago in 2025.

How bacteria inhibit gene expression
Journal News

How bacteria inhibit gene expression

Dec. 5, 2023

Researchers show how altering activity of the transcription factor CarD can cause downregulation and upregulation of some genes.